Search results for "Endotamponade"

showing 5 items of 5 documents

ACUTE VISION LOSS AS THE ONLY SIGN OF LEUKEMIA RELAPSE.

2016

Purpose To report a case of unilateral exudative retinal detachment as the sole presentation of relapsing B-type lymphoblastic leukemia in a 35-year-old man after 3 years of remission. Methods Case report. Results A 35-year-old man in complete remission of high-risk type B acute lymphoblastic leukemia (ALL-B) presented with acute vision loss in his left eye. Exudative retinal detachment was diagnosed at initial evaluation. Hematological and ocular studies were performed. Although there was no evidence of blood, cerebrospinal fluid, or bone marrow disease relapse, transvitreal retinochoroidal cytology identified the infiltration of lymphoblastic leukemic B cells with t(12:21) translocation a…

AdultMalemedicine.medical_specialtyVisual acuitymedicine.medical_treatmentBiopsyVisual AcuityVitrectomyAntineoplastic AgentsEndotamponadeBlindnessGastroenterology03 medical and health sciences0302 clinical medicineCerebrospinal fluidRecurrencehemic and lymphatic diseasesInternal medicineCytologyPrecursor B-Cell Lymphoblastic Leukemia-LymphomaVitrectomyBiopsymedicineHumansSilicone OilsB Acute Lymphoblastic Leukemiamedicine.diagnostic_testbusiness.industryRetinal DetachmentMagnetic resonance imagingGeneral MedicineExudative retinal detachmentFlow CytometryMagnetic Resonance ImagingOphthalmology030220 oncology & carcinogenesisAcute Disease030221 ophthalmology & optometrymedicine.symptomInjections IntraocularbusinessRetinal casesbrief reports
researchProduct

TREATMENT OF PERSISTENTLY OPEN MACULAR HOLES WITH HEAVY SILICONE OIL (DENSIRON 68) VERSUS C2F6. A PROSPECTIVE RANDOMIZED STUDY

2016

Abstract PURPOSE: To compare the efficacy of a mixture of silicone oil and perfluorohexyloctane (Densiron 68) with C2F6 gas endotamponade in the retreatment of persistently open full-thickness macular holes. METHODS: In this prospective randomized study, 21 consecutive patients who were unsuccessfully operated on for large idiopathic full-thickness macular hole were randomly assigned to undergo a second vitrectomy with 20% perfluoroethane gas (C2F6, Group A) or with Densiron 68 tamponade (Group B). PRIMARY OUTCOMES: Endpoint (12 months) full-thickness macular hole closure rate by spectral domain optical coherence tomography and logMAR corrected distance visual acuity. SECONDARY OUTCOMES: po…

MaleReoperationmedicine.medical_specialtyVisual acuitygenetic structuresmedicine.medical_treatmentVisual AcuityVitrectomyEndotamponadelaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRandomized controlled triallawVitrectomymedicineHumansSilicone OilsMacular hole Densiron Silicone oilProspective randomized studyProspective StudiesEndotamponadeHeavy silicone oilProspective cohort studyAgedAged 80 and overFluorocarbonsSettore MED/30 - Malattie Apparato Visivobusiness.industryGeneral MedicineMiddle AgedRetinal PerforationsSilicone oilSurgeryOphthalmologychemistry030221 ophthalmology & optometryFemalemedicine.symptombusinessTomography Optical Coherence030217 neurology & neurosurgeryRetina
researchProduct

Optical coherence tomography angiography evaluation of peripapillary microvascular changes after rhegmatogenous retinal detachment repair

2021

PURPOSE To evaluate the radial peripapillary capillary plexus (RPCP) vessel density (VD) and the retinal nerve fiber layer (RNFL) thickness in eyes successfully treated with pars plana vitrectomy for primary rhegmatogenous retinal detachment. METHODS In this cross-sectional multicenter clinical study, eyes with a minimum 12-month follow-up were reexamined. The RPCP VD and RNFL thickness in the rhegmatogenous retinal detachment subfields of the affected eye (study group) were compared with the corresponding areas of the healthy fellow eyes (control group). RESULTS Fifty-three eyes were included in the study. A significantly lower RPCP VD and RNFL thickness were observed in those subfields af…

MaleRetinal Ganglion Cellsgenetic structuresComputed Tomography Angiographymedicine.medical_treatmentNerve fiber layerVisual AcuityVitrectomyEyeradial peripapillary capillary plexuschemistry.chemical_compoundNerve FibersVitrectomyTomographyRetinal detachment repairRetinal detachmentGeneral MedicineMiddle AgedAxial Length Eyemedicine.anatomical_structureFemaleTomography Optical CoherencePars planamedicine.medical_specialtyBiometryOptic DiskEndotamponaderetinal detachmentOCT-angiography; Radial peripapillary capillary plexus; Retinal detachment; Retinal nerve fiber layer; Aged; Axial Length Eye; Biometry; Cross-Sectional Studies; Endotamponade; Female; Humans; Male; Middle Aged; Nerve Fibers; Optic Disk; Retinal Detachment; Retinal Ganglion Cells; Retinal Vessels; Retrospective Studies; Visual Acuity; Computed Tomography Angiography; Tomography Optical Coherence; VitrectomyOphthalmologymedicineHumansAxial LengthAgedRetrospective StudiesRetinabusiness.industryradial peripapillary capillary plexus; OCT-angiography; retinal nerve fiber layer; retinal detachmentRetinal Vesselsretinal nerve fiber layerRetinalOptical coherence tomography angiographymedicine.diseaseeye diseasesOphthalmologyCross-Sectional StudieschemistryOptical Coherencesense organsOCT-angiographybusiness
researchProduct

Heavy versus standard silicone oil in the management of retinal detachment with macular hole in myopic eyes

2011

PURPOSE: The purpose of this study was to compare pars plana vitrectomy (PPV) with 1000 cSt silicone oil endotamponade and PPV with densiron endotamponade for retinal detachment with macular hole and posterior staphyloma in highly myopic eyes. PATIENTS AND METHODS: In a prospective study, 30 eyes of 30 patients were randomly assigned to PPV and densiron (n = 15) or PPV with silicone oil (n = 15). All eyes had laser photocoagulation of the macular hole rim after PPV. Silicone oil or densiron was removed 12 weeks after surgery. Patients were followed-up for 6 months after oil removal. RESULTS: In the densiron group, the retinal reattachment rate was 100% with densiron in situ and 87% after it…

MaleTime FactorsVisual acuityIntraoperative Complicationgenetic structuresmedicine.medical_treatmentVisual AcuityRetinal perforationVitrectomyPostoperative ComplicationsVitrectomySilicone OilsProspective StudiesEndotamponadeIntraoperative ComplicationsMacular holeLaser Coagulationhigh myopic eyeRetinal detachmentGeneral MedicineMiddle AgedTreatment Outcomemedicine.anatomical_structureMyopia Degenerativemacular hole retinal detachmentDrainageFemalemedicine.symptomLaser coagulationDilatation PathologicHumanAdultPars planamedicine.medical_specialtyTime Factorsilicone oilOphthalmologymedicineHumansAgeddensironbusiness.industryRetinal DetachmentRetinal Perforationsmedicine.diseaseeye diseasesProspective StudieOphthalmologyRetinal PerforationPostoperative Complicationsense organsbusiness
researchProduct

Surgical management of retinal detachment because of macular hole in highly myopic eyes

2012

PURPOSE: The purpose of this study was to review the current management of macular hole retinal detachment in highly myopic eyes. METHODS: We searched English MEDLINE databases from January 1997 to January 2011 for surgical management of macular hole retinal detachment in highly myopic eyes. The main outcomes reported include retinal reattachment and visual acuity after primary surgery. RESULTS: Surgical procedures including pneumoretinopexy, pars plana vitrectomy with gas or silicone oil tamponade with or without laser therapy around the macular hole, and macular buckling have been the primary treatment choices. New techniques, including internal limiting membrane or epiretinal membrane pe…

medicine.medical_specialtygenetic structureshighly myopic eyeEndotamponadeOphthalmologic Surgical ProceduresRetinal detachment surgeryOphthalmologymedicineHumansMacular holetreatmentbusiness.industryRetinal DetachmentRetinal detachmentGeneral Medicinemedicine.diseaseRetinal Perforationseye diseasesmacular holeOphthalmologyCurrent managementMyopia DegenerativeRetinal Perforationsense organsbusinessOphthalmologic Surgical ProcedureHuman
researchProduct